Operating Lease, Rent Expense, Base Rent, Annual

No definition available.

Name:	til_OperatingLeaseRentExpenseBaseRentAnnual
Namespace Prefix:	til_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Operating Lease, Rent Expense, Base Rent Annual Increase, Percent

+ References

No definition available.

+ Details

Name:	til_OperatingLeaseRentExpenseBaseRentAnnualIncreasePercent
Namespace Prefix:	til_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Operating Lease, Rent Expense, Base Rent, Monthly

+ References

No definition available.

+ Details

Name:	til_OperatingLeaseRentExpenseBaseRentMonthly
Namespace Prefix:	til_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Research and Development Arrangement, Contract to Perform for Others, Term

+ References

No definition available.

+ Details

Name:	til_ResearchAndDevelopmentArrangementContractToPerformForOthersTerm
Namespace Prefix:	til_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Term of lessor's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 842
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479773/842-30-50-3

+ Details

Name:	us-gaap_LessorOperatingLeaseRenewalTerm
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	instant

- Definition

Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.

+ References

+ Details

Name:	us-gaap_LessorOperatingLeaseTermOfContract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	instant

- Definition

The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 730
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483041/730-20-50-1

+ Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481674/830-30-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 855
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483399/855-10-50-2

+ Details

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=til_ComplexTherapeuticsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=til_SynBioTxIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_LicenseAgreementTermsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=til_CommercialDevelopmentAndRegulatoryMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=til_LongTermDevelopmentAndRegulatoryMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=til_CommercialMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Subsequent Events (Details) - Subsequent Event - USD ($)	Aug. 01, 2024	Jul. 10, 2024
Complex Therapeutics LLC
Subsequent Event [Line Items]
Term of contract (in years)		15 years
Renewal term (in years)		5 years
Base rent, per month		$ 627,276
Base rent, per annually		$ 7,527,312
Rents increase in percentage		3.00%
SynBioTx, Inc
Subsequent Event [Line Items]
IO Collaboration Agreement term (in years)	10 years
License Agreement Terms \| SynBioTx, Inc
Subsequent Event [Line Items]
Licensing agreement compensation	$ 10,000,000
License Agreement Terms \| Maximum \| SynBioTx, Inc
Subsequent Event [Line Items]
Licensing agreement compensation	50,000,000
Commercial, development and regulatory milestones \| Maximum \| SynBioTx, Inc
Subsequent Event [Line Items]
Licensing agreement compensation	2,100,000,000
Long-Term regulatory milestones \| Maximum \| SynBioTx, Inc
Subsequent Event [Line Items]
Licensing agreement compensation	270,000,000
Commercial Milestones \| Maximum \| SynBioTx, Inc
Subsequent Event [Line Items]
Licensing agreement compensation	$ 1,800,000,000